EWJ vs IBB
iShares MSCI Japan ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.49% for EWJ.
- • EWJ pays a higher dividend yield (3.81%).
Side-by-side metrics
| Metric | EWJ | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.49% | 0.44% |
Dividend yield Trailing 12-month yield. | 3.81% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $22.31B | $9.09B |
YTD return | 15.23% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.83 | 0.69 |
P/E ratio | 18.66 | 24.89 |
Last price | $93.52 | $197.34 |
Inception | — | — |
Issuer | iShares | iShares |
EWJ top holdings
| 8035.T | Tokyo Electron Ltd | 4.17% |
| 8306.T | Mitsubishi UFJ Financial Group Inc | 4.14% |
| 285A.T | Kioxia Holdings Corp Ordinary Shares | 3.40% |
| 7203.T | Toyota Motor Corp | 3.12% |
| 6857.T | Advantest Corp | 2.86% |
| 8316.T | Sumitomo Mitsui Financial Group Inc | 2.79% |
| 9984.T | SoftBank Group Corp | 2.67% |
| 6501.T | Hitachi Ltd | 2.39% |
| 6758.T | Sony Group Corp | 2.31% |
| 6981.T | Murata Manufacturing Co Ltd | 2.23% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About EWJ
EWJ (iShares MSCI Japan ETF) is Japanese large- and mid-cap equities. Managed by iShares, the fund carries $22.3B in assets under management, an expense ratio of 0.49%, a dividend yield of 3.81%. Its largest holding is Tokyo Electron Ltd (8035.T), which represents 4.2% of the portfolio. Real Estate is the fund's largest sector exposure at 1.9%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.